Uniqure (QURE) had the highest return between July 7, 2024 and July 15, 2024 by a US stock with a market cap of $100M+, returning 134.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Uniqure (QURE) | 7/7/2024 - 7/15/2024 | 134.19% |
Zeo Energy (ZEO) | 7/7/2024 - 7/15/2024 | 87.56% |
A2Z Smart Technologies (AZ) | 7/7/2024 - 7/15/2024 | 83.86% |
TOYO Co, Ltd Ordinary Shares (TOYO) | 7/7/2024 - 7/15/2024 | 75.46% |
Quantumscape (QS) | 7/7/2024 - 7/15/2024 | 70.36% |
Ouster, Inc Common Stock (OUST) | 7/7/2024 - 7/15/2024 | 66.18% |
Humacyte (HUMA) | 7/7/2024 - 7/15/2024 | 56.42% |
Aurora Innovation (AUR) | 7/7/2024 - 7/15/2024 | 56.27% |
Lantheus (LNTH) | 7/7/2024 - 7/15/2024 | 56.15% |
Trump Media & Technology (DJTWW) | 7/7/2024 - 7/15/2024 | 53.7% |
Jumia Technologies (JMIA) | 7/7/2024 - 7/15/2024 | 53.49% |
Red Cat (RCAT) | 7/7/2024 - 7/15/2024 | 51.72% |
Innoviz Technologies (INVZW) | 7/7/2024 - 7/15/2024 | 50% |
Logistic Properties of the Americas (LPA) | 7/7/2024 - 7/15/2024 | 48.74% |
Pulse Biosciences (PLSE) | 7/7/2024 - 7/15/2024 | 46.47% |
Kymera Therapeutics (KYMR) | 7/7/2024 - 7/15/2024 | 46.15% |
Solaris Energy Infrastructure (SEI) | 7/7/2024 - 7/15/2024 | 46.03% |
Aeva Technologies, Inc Common Stock (AEVA) | 7/7/2024 - 7/15/2024 | 45.92% |
Alx Oncology Holdings (ALXO) | 7/7/2024 - 7/15/2024 | 45.72% |
Zevra Therapeutics (ZVRA) | 7/7/2024 - 7/15/2024 | 45.56% |
Hyliion (HYLN) | 7/7/2024 - 7/15/2024 | 45.4% |
Solid Biosciences LLC (SLDB) | 7/7/2024 - 7/15/2024 | 45.08% |
Aehr Test Systems (AEHR) | 7/7/2024 - 7/15/2024 | 44.76% |
Advantage Solutions (ADVWW) | 7/7/2024 - 7/15/2024 | 44.69% |
Terns Pharmaceuticals (TERN) | 7/7/2024 - 7/15/2024 | 44.57% |
